Venmax Drugs & Pharmaceuticals Limited announced unaudited standalone financial results for Q1 ended June 30. The company reported revenue from operations of Rs 121.03 lakhs and achieved a profit of Rs 3.74 lakhs. Total expenses stood at Rs 117.29 lakhs. The balance sheet showed improvements with cash and cash equivalents increasing to Rs 251.94 lakhs and trade receivables rising to Rs 230.81 lakhs.